Investment

Rhythm Biosciences Records First Commercial Sales from Genetype

Rhythm Biosciences Ltd (ASX: RHY) is a Melbourne-based medical diagnostics company focused on early cancer detection through affordable blood tests. The company’s flagship products, geneType™ and ColoSTAT®, offer innovative solutions in genetic risk assessment and colorectal cancer detection. Following the recent acquisition of Genetype in December 2024, Rhythm has now reported its first commercial sales […]

20th March 2025

REACH YOUR FULL POTENTIAL

Ready to elevate yourgame to new heights? Look no further!

By submitting your details below, you’ll gain exclusive access to the finest content in investment and lifestyle from KODARI Magazine. Whether you’re seeking insights into luxury living, expert investment insights, or the latest trends in high-end fashion and travel, we’ve got you covered.